?? Get the latest developments in clinical supply chain & logistics delivered to your inbox weekly: https://lnkd.in/d6NKbrNt Clinical Supply Leader will help you pinpoint inefficiencies in your supply chain, stay up to date on regulatory changes, identify potential supplier partners, and much more. Join our community today!
Clinical Supply Leader
互联网出版
Cranberry Township，Pennsylvania 929 位关注者
A trusted source for those professionals ensuring a secure clinical supply chain from drug development to post-trial.
关于我们
Clinical Supply Leader is a Life Science Connect community dedicated to facilitating seamless collaboration between key functional roles at the intersection of the clinical trial supply chain and logistics. With a primary focus on clinical operations and supply chain experts, we understand that these disciplines must collaborate to ensure the success of clinical supply management. Our community is committed to being a resource for tailored expertise and valuable insights curated to empower those entrusted with the secure, precise, and punctual delivery of life-saving treatments to patients at their respective clinical sites. We also emphasize the efficient management of product returns, reconciliation, and disposal, ensuring every aspect of the clinical supply chain is addressed securely. From the earliest stages of drug development to the intricacies of post-trial processes we cover all aspects of the clinical supply chain and logistics, from the early stages of drug development to post-trial processes.
- 网站
-
https://www.clinicalsupplyleader.com/
Clinical Supply Leader的外部链接
- 所属行业
- 互联网出版
- 规模
- 51-200 人
- 总部
- Cranberry Township，Pennsylvania
- 领域
- life sciences、clinical supply、clinical supply chain和clinical supply logistics
动态
-
The U.S. pharma industry has relied heavily on China and India to produce regulatory starting materials and APIs. The BIOSECURE Act has now emerged. Is this the first real step toward reshoring? https://lnkd.in/eXE74A9X By?Christopher Ohms, Ohms Consulting
Is The BIOSECURE Act The First Real Step Toward Reshoring?
clinicalsupplyleader.com
-
This article examines the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance and suggests ways to overcome these obstacles. https://lnkd.in/d9i57Qvw By Anthony Todd Everhart, MD, Signant Health
Lack Of Uptake By Sponsors Of The Draft FDA Recommendations For PROs In Oncology
clinicalsupplyleader.com
-
The demand for plasmid DNA products is intrinsically linked to unique market conditions and funding environments. Here's what's driving them: https://lnkd.in/dwpgwtJP By?Tony Hitchcock, principal and owner, AGH Bioconsulting
Sourcing Plasmid DNA From CDMOs Got More Challenging — Here's Why
clinicalsupplyleader.com
-
Another invitation to join a software demo just hit your inbox — one you didn’t even know about. ?? To make any individual technology decision, it must be understood in the context of your business strategy and projected growth trajectory.?This article explores how understanding your company's commercial goals, deciding between in-house and outsourced capabilities, and clearly defining requirements can help you create an effective IT road map that brings order to the chaos. https://lnkd.in/eBJy595Q By Wesley Ange and Irene Birbeck, Clarkston Consulting
Defining When To Implement Technologies To Support Commercial Growth
clinicalsupplyleader.com
-
Read part 2 of this series on the most common questions encountered by Dr. Bettine Boltres on scientific affairs and technical solutions for glass. https://lnkd.in/eH_9NF-p By Abigail Hisler, Global Biologics Marketing Director, West Pharmaceutical Services
The 10 Most Frequently Asked Questions On Glass: Part 2
clinicalsupplyleader.com
-
Explore the most common questions encountered by Dr. Bettine Boltres, an expert focused in scientific affairs and technical solutions for glass. https://lnkd.in/e-C4drw8 By Abigail Hisler, Strategic Marketing Director, Biologics, West Pharmaceutical Services
The 10 Most Frequently Asked Questions On Glass – Part I
clinicalsupplyleader.com
-
Confused about FDA's draft guidance on potency assays for cell and gene therapy products? Let's clarify a few things and discuss some key considerations. https://lnkd.in/ebgcBgDe By Diana Colleluori, PhD, MBA, principal CMC consultant, Biologics Consulting Group
Considerations For Potency Assurance Of CGT Products
clinicalsupplyleader.com
-
Transitioning from clinical-stage operations to commercial readiness is a multifaceted process. Establish compliant and robust distribution systems by focusing on these 3 areas: https://lnkd.in/e57FE85e By?Christopher Ohms, Ohms Consulting
3 Focus Areas To Transition From Clinical To Commercial Readiness
clinicalsupplyleader.com
-
Discover how automation and the underlying chemistry of Recce Pharmaceuticals Ltd's R327 candidate have helped the antibiotic developer reach notably high production volumes. https://lnkd.in/eJZwJ4ws A conversation with James Graham, CEO, Recce Pharmaceuticals Ltd
How Recce Is Delivering 5,000 Doses Per Week For Its Clinical Trials
clinicalsupplyleader.com